FDA’s Recent Outlook and New Policies for Cell and Gene Therapies

Mon, Feb 11, 2019 | By Tom Heinzen, VP, Corporate Development & Investor Relations, Cryoport

On January 15th FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D, Director of the Center for Biologics Evaluation and Research released a public statement which outlined new...

Why Evaporative Cooling Shippers Are Not Optimal for Pharmaceutical Applications in the 2-8°C Range

Wed, Jan 23, 2019 | By Nathan Dai, Senior Director, Business Development, Cryoport

Evaporative cooling uses evaporation from a pocket of fluid to achieve cooling inside a shipping container, often targeting the 2-8°C range. Although it might be useful for situations with less...

Can You Ship Biological Samples Currently Stored or Shipped with Dry Ice (-0 to -80°C) in Cryoport’s Dry Vapor Shipper at -150°C?

Thu, Dec 20, 2018 | By Soren H. Knudsen, Commercial Director, EMEA, Cryoport

The short answer is: YES!If a specimen or biological material can transition through the freezing point — as happens when frozen in refrigerators and/or packed in dry ice — then holding it at...

What Do You Know About Your Dry Vapor Shipper and its Potential Impact on your Critical Materials?

Mon, Nov 19, 2018 | By Kirk Randall, Senior Director, Business Development, Cryoport

Dry vapor shipping dewars used for transport of critical temperature-controlled biomaterials and lifesaving materials, such CAR-T and other regenerative medicines, can be purchased and used by...

The Critical Need for the End to End Data Flows for Regenerative Therapies

Thu, Nov 08, 2018 | By Tom Heinzen, VP, Corporate Development & Investor Relations, Cryoport

The global commercial approval of the first CAR-T therapies (Kymriah® and Yescarta®) has intensified the need for the clear and uninterrupted flow of data from before the patient is ever treated...

Beyond Logistics – What’s Needed for Successful Support of Clinical Trials and Commercialization in Regenerative Medicine?

Wed, Oct 31, 2018 | By Sue Blecman, Senior Director, Business Development, Cryoport

The tedious process of vendor selection for Clinical Trials, Commercialization Planning and Launch in Regenerative Medicine can be daunting, let alone having to think about the Support necessary...

Transportation Safety: Same and Different Across Countries

Wed, Oct 03, 2018 | By Nathan Dai, Senior Director, Business Development, Cryoport

With today’s research collaboration, supply chain distribution, clinical and commercial programs spanning across continents, it is essential for pharmaceutical or biotechnology companies to safely...

The Emergence of Chain of Compliance™

Mon, Sep 24, 2018 | By Allie Gerber, Marketing Manager, Cryoport

In December 2016 the US Congress enacted the 21st Century Cures Act, which required the FDA to facilitate an efficient development program for, and expedite the review of, new medicines meeting...

Are You Securing “Smooth” Compliant Movement of Your Biological Materials?

Wed, Sep 12, 2018 | By Soren H. Knudsen, Commercial Director, EMEA, Cryoport

Moving time and temperature sensitive biological materials “smoothly” across the globe, from A to B, is and requires more than “just” acquiring compliant packaging material and booking a carrier…...

Compliance Considerations Driving Temperature-Controlled Logistics

Tue, Sep 04, 2018 | By Ryan Carpentier, Sr. Director, Business Development, Cryoport

When considering your temperature-controlled logistics needs, it is important to think about the compliance consideration steps in the drug development and delivery process being more than just...

Cryoport’s Temperature Controlled Logistics Solutions Supporting Regenerative Medicine Advanced Therapy (RMAT) Clinical Development

Mon, Aug 27, 2018 | By Colin Coffua, Vice President of Strategic Cryoport

Cryoport’s unique range of Cold Chain Logistics Solutions have been developed and implemented to support the most important and advanced drugs currently in the clinical development portfolios of...

Scientific Conclusions Are All About the Data--Choosing a Logistics Provider For Biomaterial Transport Should Be As Well

Mon, Aug 20, 2018 | By Kirk Randall, Senior Director, Business Development, Cryoport

In our previous blog we discussed key considerations in the transport of critical biomaterials such as cell and gene therapies, in vitro fertilization shipments or large laboratory bio-sample...

Considerations for Successful Biomaterial Transport into Challenging Countries

Thu, Aug 02, 2018 | By Sue Blecman, Senior Director, Business Development, Cryoport

Successful research, development, manufacturing and commercialization in regenerative medicine is an epic challenge, with potentially a more epic reward of saving lives.Almost equally challenging...

Transporting Life: A Journey of Choice

Fri, Jul 27, 2018 | By Bruce Bowman, Sr. Director of Channel Sales, Cryoport

Graduating classes of young professionals all over the world are preparing to meet new challenges set before them as the embark on a journey. The lessons and academic content taught in their...

Dry Vapor: The Hero for the Ever-Growing CO2 Shortage

Tue, Jul 10, 2018 | By Mark W. Sawicki, Ph.D., Chief Commercial Officer, Cryoport

A carbon dioxide (CO2) shortage has been looming over the life sciences industry — yet many biopharma and biotech leaders alike have remained silent on this issue which is already shaking up our...

Cryoport is the Complete Logistics Solution for Your Clinical Programs

Thu, Oct 19, 2017 | By Allie Gerber, Marketing Manager, Cryoport

Cryoport is the leader in cryogenic and cold chain logistics solutions for the life sciences industry with their wide variety of Cryoport Express® dry vapor shippers, unparalleled informatics and...

Cold Chain Solutions for Autologous Cell Therapy Commercialization

Wed, Dec 14, 2016 | By Mark W. Sawicki, Ph.D., Chief Commercial Officer, Cryoport

Biopharmaceuticals are inherently fragile and temperature-sensitive, requiring exacting control of shipping and storage conditions to maintain product efficacy. This is especially critical for...

Using Real-World Data to Reduce Cold Chain Risk

Wed, Nov 09, 2016 | By Mark W. Sawicki, Ph.D., Chief Commercial Officer, Cryoport

When planning your cold chain logistics strategy for temperature-sensitive biologic materials, a key consideration is minimizing risk to the quality of the commodity and its on-time delivery....

Outsourcing Dewar Management to Improve Human and Animal Health Operations

Wed, Sep 28, 2016 | By Mark W. Sawicki, Ph.D., Chief Commercial Officer, Cryoport

Today, an increasing number of therapeutics and vaccines for human and animal administration require shipment in specialized shipping containers often referred to as dewars or cryoshippers. Dewars...

Cryoport Now Supports Laboratory Relocation

Thu, Aug 11, 2016 | By Mark W. Sawicki, Ph.D., Chief Commercial Officer, Cryoport

Moving a laboratory can be stressful. No matter the scope of the relocation, the logistical and physical act of moving laboratories tends to be an inconvenience that disturbs the flow of...

Notes From The Field – Minimizing Cold Chain Risk for Regenerative Medicines

Wed, Dec 02, 2015 | By Robert Hariri, M.D., Ph.D., Board of Directors, Cryoport

By Robert Hariri, M.D., Ph.D.

For years, there has been a need for logistics methodologies to keep pace with the developments in biology that require reliable and environmentally controlled...

Cryoport Allows Yancey Farms to Meet Peak Demand During Breeding Season

Mon, Aug 10, 2015 | By Marketing Team, Cryoport

Another breeding season is coming to a close at Yancey Farms. Yancey Farms is one of the oldest and most respected warmblood breeders in the United States. They have been producing sporthorses of...

The Top 5 Hidden Costs of Dry Ice Shipping

Tue, Jul 08, 2014 | By Marketing Team, Cryoport

The combination of dry ice, Styrofoam® and overnight shipping worked miracles in the 1960s and transformed medicine on the battlefield and here at home. Today, that combination remains a popular...

Cryoport, the Company Behind the Technology used in the FedEx® Deep Frozen Shipping Solution

Wed, Jun 25, 2014 | By Marketing Team, Cryoport